Considering that ACE2 showed preferential localization in the surfactant-producing type II alveolar cells, as well as the respiratory ciliated epithelial cells, patients with COVID-19 and inflammatory lung injury will exhibit reduced surfactant and susceptibility for lung collapse, justifying the respiratory deterioration in severe cases [29]. Here, ACE2 is linked to COVID-19.